Structural mechanism of membrane remodeling during herpesvirus nuclear egress

疱疹病毒核排出过程中膜重塑的结构机制

基本信息

  • 批准号:
    9037679
  • 负责人:
  • 金额:
    $ 30.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-04-01 至 2018-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Herpesviruses are omnipresent human pathogens that cause a number of important diseases. Devising better strategies to combat these viruses requires the in-depth understanding of how they replicate. This proposal focuses on nuclear egress during which nucleocapsids bud into the inner nuclear membrane, a critical step in the assembly and release of progeny virions. The viral nuclear egress complex (NEC) is the key player in this process, but the detailed mechanistic knowledge of its function is lacking. The long-term goal of this research is to elucidate the atomic-level mechanism of herpesvirus nuclear egress, to improve the fundamental knowledge of this process and to identify and characterize novel antiviral targets. The objective of this proposal is to fully explore the mechanism of NEC-mediated membrane deformation during nuclear egress by using an amalgamation of structural, biophysical, and cell-based strategies. This proposal is driven by the central hypothesis, based on substantial preliminary data, that the NEC alone mediates membrane budding and, possibly, scission in oligomerization-dependent manner. Aim 1 will focus on determining the mechanism of membrane deformation by the HSV-1 NEC by using the in vitro membrane budding assay with giant unilamellar vesicles (GUVs) in combination with light microscopy and cryoelectron microscopy. The membrane budding assay will also be used to reconstitute capsid budding in vitro. The goal of Aim 2 is determine the structure of the HSV-1 NEC and to map functionally important regions by structure- guided mutagenesis in combination with in vitro assays and the in vivo characterization of recombinant viruses. Aim 3 will concentrate on revealing the conserved and the virus-specific features of the NEC mechanism in alpha and gamma-herpesviruses by extending the biochemical and the structural studies to NECs from pseudorabies, Epstein-Barr, and Kaposi's Sarcoma herpesviruses. The proposed work will leverage the combined expertise in biochemistry and structural biology (Heldwein lab) with expertise in virus mutagenesis and live-cell fluorescent imaging (Smith lab). The outcome of these studies will be the structure of the NEC and the mechanism by which it enables membrane deformation during nuclear egress. Obtaining the crystal structure of the NEC will have a major impact in the field of herpes virology by yielding mechanistic and functional insights unavailable by any other approaches. Furthermore, detailed in vitro studies of the NEC-mediated membrane budding may uncover a novel membrane budding mechanism. Importantly, by correlating the in vitro properties of the NEC mutants with the in vivo phenotypes of the corresponding recombinant viruses, the NEC structure and the observations from in vitro budding models will be directly related to the nuclear egress in infected cells. A detailed knowledge of the structural mechanism of membrane remodeling by the NEC during nuclear egress will benefit not just the herpesvirus field, but also significantly advance the current knowledge of cellular processes.
描述(由申请人提供):疱疹病毒是一种无所不在的人类病原体,可引起多种重要疾病。设计更好的策略来对抗这些病毒需要深入了解它们是如何复制的。该建议的重点是核出口,在此期间,核衣壳出芽进入内核膜,这是子代病毒体组装和释放的关键步骤。病毒核出口复合物(NEC)是这一过程中的关键参与者,但其功能的详细机制知识是缺乏的。本研究的长期目标是阐明疱疹病毒核出口的原子水平机制,提高这一过程的基础知识,并确定和表征新的抗病毒靶点。本提案的目的是充分探索NEC介导的膜变形的机制,在核出口通过使用结构,生物物理和细胞为基础的策略的合并。这一提议是由基于大量初步数据的中心假设驱动的,即NEC单独以寡聚化依赖性方式介导膜萌芽和可能的断裂。目的1将集中于通过使用巨单层囊泡(GUV)的体外膜出芽试验结合光学显微镜和冷冻电子显微镜来确定HSV-1 NEC的膜变形机制。膜出芽测定也将用于在体外重建衣壳出芽。目的2的目标是确定HSV-1 NEC的结构,并通过结构导向诱变结合体外测定和重组病毒的体内表征来定位功能重要区域。目的3将集中于揭示保守的和病毒特异性的特征,NEC机制在α和γ-疱疹病毒通过扩展的生物化学和结构研究NEC从伪狂犬病,EB病毒,卡波西肉瘤疱疹病毒。拟议的工作将利用生物化学和结构生物学(Heldwein实验室)的专业知识与病毒诱变和活细胞荧光成像(Smith实验室)的专业知识相结合。这些研究的结果将是NEC的结构和机制,它使膜变形在核出口。获得NEC的晶体结构将在疱疹病毒学领域产生重大影响,产生任何其他方法都无法获得的机制和功能见解。此外,详细的体外研究NEC介导的膜出芽可能会发现一个新的膜出芽机制。重要的是,通过将NEC突变体的体外性质与相应重组病毒的体内表型相关联,NEC结构和来自体外出芽模型的观察结果将与感染细胞中的核排出直接相关。详细了解NEC在核出口过程中膜重塑的结构机制不仅有利于疱疹病毒领域,而且还显着推进了细胞过程的现有知识。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ekaterina Heldwein其他文献

Ekaterina Heldwein的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ekaterina Heldwein', 18)}}的其他基金

In-vitro analysis of HSV-1 membrane fusion mechanism
HSV-1膜融合机制的体外分析
  • 批准号:
    10373110
  • 财政年份:
    2021
  • 资助金额:
    $ 30.95万
  • 项目类别:
Structure, antigenicity, and function of HCMV fusogen gB
HCMV融合剂gB的结构、抗原性和功能
  • 批准号:
    10315349
  • 财政年份:
    2021
  • 资助金额:
    $ 30.95万
  • 项目类别:
In-vitro analysis of HSV-1 membrane fusion mechanism
HSV-1膜融合机制的体外分析
  • 批准号:
    10230779
  • 财政年份:
    2021
  • 资助金额:
    $ 30.95万
  • 项目类别:
Structure, antigenicity, and function of HCMV fusogen gB
HCMV融合剂gB的结构、抗原性和功能
  • 批准号:
    10651753
  • 财政年份:
    2021
  • 资助金额:
    $ 30.95万
  • 项目类别:
Structure, antigenicity, and function of HCMV fusogen gB
HCMV融合剂gB的结构、抗原性和功能
  • 批准号:
    10424572
  • 财政年份:
    2021
  • 资助金额:
    $ 30.95万
  • 项目类别:
Single-particle analysis of HSV-1 membrane fusion mechanism
HSV-1膜融合机制的单粒子分析
  • 批准号:
    10252827
  • 财政年份:
    2020
  • 资助金额:
    $ 30.95万
  • 项目类别:
Biophysical and structural analysis of the herpesviral nuclear budding machinery
疱疹病毒核出芽机制的生物物理和结构分析
  • 批准号:
    10159089
  • 财政年份:
    2019
  • 资助金额:
    $ 30.95万
  • 项目类别:
Biophysical and structural analysis of the herpesviral nuclear budding machinery
疱疹病毒核出芽机制的生物物理和结构分析
  • 批准号:
    10415170
  • 财政年份:
    2019
  • 资助金额:
    $ 30.95万
  • 项目类别:
Biophysical and structural analysis of the herpesviral nuclear budding machinery
疱疹病毒核出芽机制的生物物理和结构分析
  • 批准号:
    10646492
  • 财政年份:
    2019
  • 资助金额:
    $ 30.95万
  • 项目类别:
The prefusion form of HSV-1gB
HSV-1gB 的预灌输形式
  • 批准号:
    8967556
  • 财政年份:
    2014
  • 资助金额:
    $ 30.95万
  • 项目类别:

相似海外基金

Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
  • 批准号:
    23K18186
  • 财政年份:
    2023
  • 资助金额:
    $ 30.95万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
  • 批准号:
    10560883
  • 财政年份:
    2023
  • 资助金额:
    $ 30.95万
  • 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10730692
  • 财政年份:
    2021
  • 资助金额:
    $ 30.95万
  • 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
  • 批准号:
    21K06459
  • 财政年份:
    2021
  • 资助金额:
    $ 30.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10189880
  • 财政年份:
    2021
  • 资助金额:
    $ 30.95万
  • 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
  • 批准号:
    2404261
  • 财政年份:
    2020
  • 资助金额:
    $ 30.95万
  • 项目类别:
    Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10222540
  • 财政年份:
    2020
  • 资助金额:
    $ 30.95万
  • 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10669717
  • 财政年份:
    2020
  • 资助金额:
    $ 30.95万
  • 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
  • 批准号:
    20K10713
  • 财政年份:
    2020
  • 资助金额:
    $ 30.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10174522
  • 财政年份:
    2020
  • 资助金额:
    $ 30.95万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了